Page last updated: 2024-10-22

tyrphostin ag 1024 and Body Weight

tyrphostin ag 1024 has been researched along with Body Weight in 2 studies

tyrphostin AG 1024: modulates radiosensitivity in human breast cancer cells; also an IGF1 receptor inhibitor

Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.

Research Excerpts

ExcerptRelevanceReference
" In the first part of the study, rats were assigned to sham control, ischemic control, and ischemia with different dosages of IGF 1 injection groups to determine the optimal dosage of IGF 1 on preventing muscle atrophy after brain ischemia."1.36Effects of insulin-like growth factor 1 on muscle atrophy and motor function in rats with brain ischemia. ( Chang, HC; Kuo, CH; Wang, PS; Wang, RY; Yang, YR, 2010)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Elhenawy, AA1
Ashour, RH1
Nabih, N1
Shalaby, NM1
El-Karef, AA1
Abou-El-Wafa, HS1
Chang, HC1
Yang, YR1
Wang, PS1
Kuo, CH1
Wang, RY1

Other Studies

2 other studies available for tyrphostin ag 1024 and Body Weight

ArticleYear
Insulin growth factor inhibitor as a potential new anti-schistosoma drug: An in vivo experimental study.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2017, Volume: 95

    Topics: Animals; Antigens, Helminth; Body Weight; Female; Glucose Transporter Type 4; Homeostasis; Insulin R

2017
Effects of insulin-like growth factor 1 on muscle atrophy and motor function in rats with brain ischemia.
    The Chinese journal of physiology, 2010, Oct-31, Volume: 53, Issue:5

    Topics: Animals; Body Weight; Brain Ischemia; Dose-Response Relationship, Drug; Infarction, Middle Cerebral

2010